Literature DB >> 8063206

Budd-Chiari syndrome in a young patient with anticardiolipin antibodies: need for prolonged anticoagulant treatment.

R J Ouwendijk1, J C Koster, J H Wilson, J Stibbe, J S Lameris, W Visser, J P Benhamou.   

Abstract

The case of a 20 year old woman is reported with Budd-Chiari syndrome in whom lupus anticoagulant and anticardiolipin antibodies were shown; treatment with oral anticoagulants induced a considerable improvement. This treatment was interrupted after one year; interruption was followed by redevelopment of ascites. Further treatment with anticoagulants was continued for five years with noticeable improvement. When treatment with oral anticoagulants was stopped because of pregnancy, the patient redeveloped ascites and had a spontaneous miscarriage. Subsequently, treatment with oral anticoagulants was reintroduced and again resulted in noticeable improvement. In conclusion patients with Budd-Chiari syndrome should be tested for lupus anticoagulants and anticardiolipin antibodies, Budd-Chiari syndrome resulting from this cause may have a good response to treatment with oral anticoagulants; this treatment should be maintained permanently, and pregnancy in such patients may initiate serious difficulties.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063206      PMCID: PMC1374853          DOI: 10.1136/gut.35.7.1004

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  Successful pregnancy after Budd-Chiari syndrome.

Authors:  C Vons; C Smadja; D Franco; D Valla; B Rueff; J P Benhamou
Journal:  Lancet       Date:  1984-10-27       Impact factor: 79.321

2.  Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation.

Authors:  L O Carreras; G Defreyn; S J Machin; J Vermylen; R Deman; B Spitz; A Van Assche
Journal:  Lancet       Date:  1981-01-31       Impact factor: 79.321

3.  Inferior vena cava stenosis and Budd--Chiari syndrome in a woman taking oral contraceptives.

Authors:  G Lalonde; G Théoret; P Daloze; P Bettez; S S Katz
Journal:  Gastroenterology       Date:  1982-06       Impact factor: 22.682

4.  Budd-Chiari syndrome with inferior vena cava obstruction associated with systemic lupus erythematosus.

Authors:  T F Disney; S N Sullivan; R G Haddad; D Lowe; M M Goldbach
Journal:  J Clin Gastroenterol       Date:  1984-06       Impact factor: 3.062

5.  Budd-Chiari syndrome in a patient with the lupus anticoagulant.

Authors:  C Pomeroy; R G Knodell; W R Swaim; P Arneson; M L Mahowald
Journal:  Gastroenterology       Date:  1984-01       Impact factor: 22.682

6.  Hepatitis in patients with acute nonlymphocytic leukemia.

Authors:  J C Wade; M Gaffey; P H Wiernik; S C Schimpff; C A Schiffer; M Wesley; J H Hoofnagle
Journal:  Am J Med       Date:  1983-09       Impact factor: 4.965

7.  Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.

Authors:  E N Harris; A E Gharavi; M L Boey; B M Patel; C G Mackworth-Young; S Loizou; G R Hughes
Journal:  Lancet       Date:  1983-11-26       Impact factor: 79.321

8.  Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus.

Authors:  M D Lockshin; M L Druzin; S Goei; T Qamar; M S Magid; L Jovanovic; M Ferenc
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

9.  A sensitive test demonstrating lupus anticoagulant and its behavioural patterns.

Authors:  T Exner; K A Rickard; H Kronenberg
Journal:  Br J Haematol       Date:  1978-09       Impact factor: 6.998

10.  Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin.

Authors:  L H Silveira; C L Hubble; L J Jara; S Saway; P Martínez-Osuna; M J Seleznick; J Angel; W O'Brien; L R Espinoza
Journal:  Am J Med       Date:  1992-10       Impact factor: 4.965

View more
  4 in total

Review 1.  Liver cirrhosis in hepatic vena cava syndrome (or membranous obstruction of inferior vena cava).

Authors:  Santosh Man Shrestha
Journal:  World J Hepatol       Date:  2015-04-28

Review 2.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

3.  Suprahepatic Budd-Chiari syndrome treated with thrombectomy and cavoplasty.

Authors:  John Rhee; Anthony J Demetris; Kareem Abu Elmagd; Mordechai Rabinovitz
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

Review 4.  Unusual manifestations of the antiphospholipid syndrome.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.